• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2025 Apr;19(4):e70094.
doi: 10.1111/irv.70094. Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics

Sabina O Nduaguba[SUP] 1 2 3 [/SUP], Phuong T Tran[SUP] 1 4 [/SUP], Renata Shih[SUP] 5 [/SUP], Lyn Finelli[SUP] 6 [/SUP], Yoonyoung Choi[SUP] 6 [/SUP], Yanning Wang[SUP] 7 8 [/SUP], Almut G Winterstein[SUP] 1 7 9 [/SUP]



Affiliations
Free article Abstract

Objectives: This study aimed to estimate the incidence of respiratory syncytial virus (RSV) infections in US inpatient and outpatient settings.
Methods: We established national cohorts of privately insured children < 5 years (2011-2019) to estimate annual and seasonal incidences of lower respiratory tract infection (LRTI), RSV-LRTI, and RSV acute respiratory infection (RSV-ARI), stratified by age and high-risk conditions per American Academy of Pediatrics definitions. Sensitivity analyses varied episode definitions and assessed the impact of immunoprophylaxis and RSV under-ascertainment.
Results: Among 6,767,107 children, annual RSV-LRTI rates dropped with increasing age in both inpatient (7.9 for age < 1 year to 0.2 for age 4 per 1000 person-years) and outpatient settings (48.3 to 1.6). Most RSV-ARI (~80%-90%) was RSV-LRTI. RSV-LRTI accounted for > half of LRTI hospitalizations among infants (7.9 RSV-LRTI versus 14.7 LRTI) and for ~20% outpatient LRTI (48.3 versus 250.3), but this contribution declined with older age. Outpatient RSV-LRTI was > 5 times inpatient rates. Inpatient RSV-LRTI rates dropped consistently with increasing gestational age (GA) (35.6 for GA < 29 weeks versus 7.6 for term infants), while outpatient rates were similar across GA groups (54.0 versus 51.6). Infants with Down syndrome had the highest RSV-LRTI rates, and any high-risk group had rates >2 times higher than healthy term infants. Across all strata, seasonal rates were > 2 annual rates. Modeling suggested that claims data captured 42% of all RSV episodes.
Conclusion: This study provides national, population-based estimates of medically attended RSV infections across age groups and high-risk strata. Results allow granular assessments of disease burden to guide recommendations for new RSV prevention strategies.

Keywords: epidemiologic methods; incidence; respiratory syncytial virus infection.

 
Back
Top Bottom